MAIN MOLECULAR TARGETS FOR PROSTATE CANCER THERAPY

MAIN MOLECULAR TARGETS FOR PROSTATE CANCER THERAPY

Androgenic pathway plays a pivotal role in the development of benign and malignant prostate tumors. Most of the prostate neoplasms are hormone-dependent at the time of diagnosis. Therapeutic interventions aimed at reducing the level of testosterone in the blood allow to stop progression of the disea...

Full description

Bibliographic Details
Main Authors: G. S. Krasnov, A. A. Dmitriev, N. N. Volchenko, T. V. Danilova, A. F. Sadritdinova, A. V. Snezhkina, N. V. Melnikova, M. S. Fedorova, V. A. Lakunina, A. A. Belova, B. Y. Alekseev, A. D. Kaprin, A. V. Kudryavtseva
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2016-02-01
Series:Сибирский онкологический журнал
Subjects:
castrate resistant prostate cancer
androgen receptor
abiraterone
enzalutamide
mv3100
galeterone
vt-464
cyp17а1
Online Access:https://www.siboncoj.ru/jour/article/view/286

Similar Items

Similar Items